News
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
6d
New Scientist on MSNDrugs like Ozempic and Wegovy could significantly cut dementia riskDozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...
Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...
12d
Verywell Health on MSNContrave vs. Wegovy: How Do They Compare for Weight Loss?Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...
Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
Ozempic (semaglutide) and Wegovy (semaglutide) are brand-name injections. Ozempic is approved for type 2 diabetes, but doctors may sometimes prescribe it off-label for weight loss and management.
A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...
Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results